Free Trial

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical logo
$422.06 -5.58 (-1.30%)
Closing price 10/13/2026 04:00 PM Eastern
Extended Trading
$421.94 -0.12 (-0.03%)
As of 10/13/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
7
Buy
23

Based on 31 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 31 analysts, 1 has given a sell rating, 7 have given a hold rating, 22 have given a buy rating, and 1 has given a strong buy rating for ISRG.

Consensus Price Target

$498.83
18.19% Upside
According to the 31 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $498.83. The highest price target for ISRG is $685.00, while the lowest price target for ISRG is $357.44. The average price target represents a forecasted upside of 18.19% from the current price of $422.06.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISRG Analyst Ratings Over Time

TypeCurrent Forecast
10/14/25 to 10/14/26
1 Month Ago
9/14/25 to 9/14/26
3 Months Ago
7/16/25 to 7/16/26
1 Year Ago
10/14/24 to 10/14/25
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
22 Buy rating(s)
22 Buy rating(s)
19 Buy rating(s)
14 Buy rating(s)
Hold
7 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$498.83$508.68$562.62$585.71
Forecasted Upside18.19% Upside34.59% Upside39.84% Upside34.22% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Intuitive Surgical Stock vs. The Competition

TypeIntuitive SurgicalHealthcare CompaniesBroader Market
Consensus Rating Score
2.74
2.32
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside18.19% Upside1,080.73% Upside19.09% Upside
News Sentiment Rating
Positive News

See Recent ISRG News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/13/2026
UBS Group AG logo
UBS Group
4 of 5 stars
Patrick Wood
Not Rated
Reiterated RatingBuy
10/13/2026
Mizuho logo
Mizuho
3 of 5 stars
Anthony Petrone
Anthony Petrone
4 of 5 stars
Set Target$415.00-1.39%
10/12/2026
BTIG Research logo
BTIG Research
3 of 5 stars
Ryan Zimmerman
Ryan Zimmerman
3 of 5 stars
Lower TargetBuy$469.00 ➝ $454.00+7.09%
10/7/2026UpgradeStrong-Buy
8/21/2026Reiterated RatingOverweight
8/14/2026 Reiterated RatingHold (C)
8/12/2026Reiterated RatingOutperform
8/12/2026 Reiterated RatingOverweight
8/12/2026UpgradeMarket Perform ➝ Outperform$500.00+24.62%
7/30/2026DowngradeBuy ➝ Hold$391.00+10.73%
7/28/2026 UpgradeOutperform
7/28/2026DowngradeBuy ➝ Hold
7/20/2026Reiterated RatingOutperform
7/17/2026Reiterated RatingOutperform$577.00 ➝ $483.00+34.54%
7/17/2026Reiterated RatingOverweight$654.00 ➝ $487.00+21.04%
7/17/2026Lower TargetOverweight$550.00 ➝ $450.00+27.00%
7/17/2026Lower TargetBuy$670.00 ➝ $550.00+36.70%
7/17/2026Lower TargetBuy$590.00 ➝ $500.00+24.28%
7/17/2026Lower TargetOutperform$525.00 ➝ $500.00+24.28%
7/17/2026Lower TargetOutperform$573.00 ➝ $454.00+12.84%
7/16/2026Lower TargetBuy$580.00 ➝ $510.00+27.78%
7/13/2026Lower TargetOutperform$650.00 ➝ $600.00+46.77%
7/6/2026 Set Target$430.00+1.32%
6/12/2026 Lower Target$520.00 ➝ $515.00+26.78%
6/2/2026 Lower TargetSell$440.00 ➝ $366.00-8.82%
5/27/2026Set Target$558.00+30.63%
4/22/2026 Lower TargetHold$560.00 ➝ $515.00+7.00%
3/30/2026 DowngradeStrong-Buy ➝ Hold
2/4/2026 Lower TargetBuy$630.00 ➝ $560.00+17.03%
10/24/2025 Boost TargetOutperform$510.00 ➝ $550.00+0.28%
10/23/2025 Boost TargetBuy$610.00 ➝ $615.00+16.69%
7/23/2025 Reiterated RatingBuy ➝ Hold
1/27/2025 Initiated CoverageNeutral$550.00-4.17%
1/27/2025 Boost TargetOverweight$655.00 ➝ $700.00+22.16%
12/2/2024 UpgradeEqual Weight ➝ Overweight$522.00 ➝ $650.00+19.93%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:25 AM ET.


Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 8, 2026. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

  • Intuitive Surgical, Inc. recently demonstrated strong financial performance by beating consensus estimates in its most recent quarterly report, posting earnings per share of $2.80 against an expected $2.48 and generating revenue of $2.89 billion, which represented an 18.4% year-over-year increase. This consistent ability to exceed analyst expectations for both earnings and revenue suggests robust operational execution and demand for the company's robotic-assisted systems, providing a fundamental basis for potential stock appreciation.
  • The stock is currently trading at $415.41, which is significantly below the consensus price target of $508.68 set by analysts as of September 2026. This valuation gap implies that the market may be undervaluing the company relative to its projected growth, offering investors a potential entry point with substantial upside potential if the stock reverts to the mean of analyst expectations.
  • Wall Street sentiment remains strongly positive, with a consensus rating of "Moderate Buy" and recent upgrades from major firms such as Barclays, which raised its rating to "Strong Buy," and Piper Sandler, which issued a "Buy" recommendation. These recent actions indicate that institutional investors and analysts have high confidence in the company's long-term trajectory and market position, which can drive sustained buying interest.
  • The company's da Vinci Single-Port platform is gaining significant momentum, with rising procedure volumes, utilization rates, and international adoption. This expansion into new surgical indications and geographic markets creates a new growth engine for recurring revenue, allowing Intuitive Surgical, Inc. to capture a larger share of the minimally invasive surgery market and diversify its revenue streams beyond its traditional multi-port systems.
  • Institutional investors continue to show confidence in the company, with firms like Gradient Investments LLC increasing their holdings by 5.5% in the third quarter and S.E.E.D. Planning Group LLC boosting their position by 17.1%. This accumulation of shares by professional money managers suggests that sophisticated investors view the stock as a compelling long-term hold, which can provide support for the share price during periods of market volatility.

Intuitive Surgical
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

  • Intuitive Surgical, Inc. faces intensifying competition, particularly from major healthcare conglomerates like Johnson & Johnson, which are actively entering the robotic surgery space. This increased rivalry could erode the company's market share and pricing power, as competitors offer alternative solutions that may be more cost-effective or integrated into existing hospital systems, posing a significant threat to the company's dominant position.
  • The stock carries a premium valuation with a P/E ratio of 47.58, which is high relative to many other healthcare companies. This elevated multiple leaves little room for error, meaning that any slight miss in earnings or guidance could trigger a sharp decline in the stock price, as investors may quickly reassess the company's growth prospects and demand a lower valuation.
  • Insider selling activity has been notable, with executives and directors such as Gary Guthart and Mark Brosius selling significant numbers of shares in recent months. While these sales may be part of pre-arranged trading plans, a consistent pattern of insider selling can be interpreted as a signal that company insiders believe the stock is overvalued or that they are diversifying their personal wealth, which may dampen investor sentiment.
  • The company's stock has experienced significant volatility, with a 52-week range from $328.57 to $603.88, indicating high beta of 1.46. This level of volatility means that the stock is more sensitive to market movements and news events, which can lead to large price swings that may not be justified by fundamental changes, making it a riskier investment for those with lower risk tolerance.
  • Short interest in the stock has been increasing, with shares shorted rising to 8.1 million as of September 2026, representing a 5.03% month-over-month increase. This growing short interest suggests that some investors are betting against the stock, potentially due to concerns about competition, valuation, or future growth, which could lead to further downward pressure on the share price if the bearish thesis gains traction.

ISRG Forecast - Frequently Asked Questions

According to the research reports of 31 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $498.83, with a high forecast of $685.00 and a low forecast of $357.44.

31 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There is currently 1 sell rating, 7 hold ratings, 22 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ISRG shares.

According to analysts, Intuitive Surgical's stock has a predicted upside of 18.19% based on their 12-month stock forecasts.

Over the previous 90 days, Intuitive Surgical's stock had 4 upgrades and 2 downgrades by analysts.

Analysts like Intuitive Surgical more than other "healthcare" companies. The consensus rating for Intuitive Surgical is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how ISRG compares to other companies.


MarketBeat monitors more than a dozen sources for Intuitive Surgical analyst ratings, with the most recent rating issued on 10/13/2026.
From Our Partners